🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Notice that is beta hemolytic. The A disk is Bacitracin- if growth was inhibited by Bacitracin then we would be concerned that this is micrococcus instead of Staph. @Eunjijang89 Sara Khalife Sabina Holland, MD Ian Michelow Penny Dennehy

Excited to help with the #SLUIM #AMS initiative on #UTIs rolling out soon. Love this review from Katrina M Byrd, MD !

Negative preliminary blood culture results often affect PICC insertion times prior to OPAT therapy... How do we know which blood culture positive results are likely contaminants? Here is a list from Katrina M Byrd, MD

Looking forward to our upcoming SLU IM URM Open House. Please continue to share! #MedTwitter #Match2023 The Student National Medical Association (SNMA) SNMA Region II Project Diversify Medicine

We had a great time at ACPMissouri! So proud of our residents for presenting their scholarly work! Christian Hendrix, MD She/Hers won🥇place poster in Patient Safety/QI! Sana Kiblinger, Josh Fernelius, and Ali Ahmad represented SLU at Doctor’s Dilemma!! Ravi Nayak, MD,FCCP, FRCP @DrBuckholdSLU Martin Schoen MD MPH

Congratulations to the President-Elect of the Infectious Disease Society of America (IDSA), Dr. Carlos, del Rio! Carlos del Rio Image: bit.ly/3S7U3iA, Emory Healthcare, Emory Health, Emory SOM at Grady Hospital, Emory School of Medicine

We started the discussion on Clubhouse, you can listen here: clubhouse.com/room/xlkzANDL?… (3 hours focused on slides 1-16 with input from audience members)

“We are doctors for the world, and the world needs us to speak up right now” Vinny Arora MD MAPP delivered a POWERFUL Keynote Address at ACP #IM2023 She made it clear there is no opting out with her inspiring call to action!

【Durations of Therapy for Diabetic Foot Infections】 Let's remember the typical durations of therapy for DFI! Level: Intermediate Importance: ★★★ academic.oup.com/cid/advance-ar… Clinical Infectious Diseases Nico Cortes-Penfield MD FACP FIDSA 🦴💊 Jonathan Ryder, MD David G. Armstrong follow @dgarmstrong.bsky.social TzeWoeiTan, MBBS, MPH, FACS Marcos Schechter IDSA Medical Education Community of Practice

STI Treatments Quick Sheet 🦠💊 Get a PDF copy from your Pyrls 📱 #IDTwitter #TwitteRx #MedTwitter

The 2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis: Updating the Modified Duke Criteria 🔗 bit.ly/47R5dl1

Last week's Medicine CPC with Nicolo Cabrera, MD, Assistant Professor @WashUID is now available for viewing on the DOM YouTube Channel.⁠ ⁠ The #WUDeptMedicine YouTube channel now offers access to previous 2024 Medicine CPC presentations. Test Account Link> internalmedicine.wustl.edu/education/clin…

The potential impact of #DoxyPEP on #syphilis diagnostic algorithms warrants monitoring: Doxycycline postexposure prophylaxis may delay seroconversion in incident syphilis | Sexually Transmitted Infections (bmj.com)

Congratulations to our 2024 Infectious Diseases Fellow Graduates! infectiousdiseases.wustl.edu/congratulation…

Inspired by a discussion on inpatient rounds this week with super ID fellow Gabriel Motoa, MD, here are a couple of great Clinical Infectious Diseases perspectives that challenge the status quo on infection control practices. First up, MRSA. doi.org/10.1093/cid/ci… 1/x

Today is July 1 and thousands of PGY-1 residents are starting today. As a PGY-41 I want to wish you success but also remind you that you are not alone so don’t be afraid to ask for help and get comfortable with saying “I don’t know”, remember you are here to learn!

Data definitely resonate with us in ID/GI, who all see people after GI illness (esp post travel) with persistent symptoms, convinced they have an ongoing infection. Sometimes they do, sometimes they don't. Challenging problem! Microbiome issue? doi.org/10.1136/gutjnl…

A 73-year-old Japanese Woman With Rheumatoid Arthritis and Exposure to Water From a Well bit.ly/3TzcVdL

Looking forward to speaking at ⁦Washington Universit⁩ on The #Palestine Taboo: Race, Islamophobia, and Free Speech | Religious Studies humanities.wustl.edu/events/palesti…